Literature DB >> 8349047

Insulin resistance in spontaneously hypertensive rats. Difference in interpretation based on insulin infusion rate or on plasma insulin in glucose clamp studies.

R H Rao1.   

Abstract

Isotopic glucose turnover was measured during euglycemic glucose clamp studies in spontaneously hypertensive rats and normotensive Wistar-Kyoto control rats, under pentobarbital sodium anesthesia. At an insulin infusion rate of 4 mU.kg-1 x min-1, glucose disposal rate and hepatic glucose output were not significantly different in either group, at a plasma glucose of 6 mM. However, steady-state plasma insulin levels in spontaneously hypertensive rats were more than double those in Wistar-Kyoto rats (2.34 +/- 0.16 [mean +/- SE] vs. 6.78 +/- 0.58 nM, P < 0.00005, n = 7 in each group). Additional studies (n = 30 in spontaneously hypertensive rats and n = 32 in Wistar-Kyoto control rats) were conducted to match insulin levels in the two groups over a wide range, using infusion rates of 0.5-10 mU.kg-1 x min-1. When the responses of glucose disposal rate and hepatic glucose output to insulin were analyzed from the standpoint of plasma insulin levels, a highly significant difference was seen in the response to insulin between spontaneously hypertensive rats and Wistar-Kyoto rats, for both glucose disposal rate (P < 0.000005) and hepatic glucose output (P = 0.00007). The slope of the regression line for glucose disposal rate versus plasma insulin was lower in spontaneously hypertensive rats compared with Wistar-Kyoto rats (2.652 vs. 4.864, P < 0.001), indicating that insulin stimulation of glucose disposal rate was reduced by 50% in spontaneously hypertensive rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349047     DOI: 10.2337/diab.42.9.1364

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension.

Authors:  M Pravenec; V Zidek; M Simakova; V Kren; D Krenova; K Horky; M Jachymova; B Mikova; L Kazdova; T J Aitman; P C Churchill; R C Webb; N H Hingarh; Y Yang; J M Wang; E M Lezin; T W Kurtz
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

2.  Complement Factor B Is a Determinant of Both Metabolic and Cardiovascular Features of Metabolic Syndrome.

Authors:  Philip M Coan; Marjorie Barrier; Neza Alfazema; Roderick N Carter; Sophie Marion de Procé; Xaquin C Dopico; Ana Garcia Diaz; Adrian Thomson; Lucy H Jackson-Jones; Ben Moyon; Zoe Webster; David Ross; Julie Moss; Mark J Arends; Nicholas M Morton; Timothy J Aitman
Journal:  Hypertension       Date:  2017-07-24       Impact factor: 10.190

3.  Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders.

Authors:  Ruisheng Song; Wei Peng; Yan Zhang; Fengxiang Lv; Hong-Kun Wu; Jiaojiao Guo; Yongxing Cao; Yanbin Pi; Xin Zhang; Li Jin; Mao Zhang; Peng Jiang; Fenghua Liu; Shaoshuai Meng; Xiuqin Zhang; Ping Jiang; Chun-Mei Cao; Rui-Ping Xiao
Journal:  Nature       Date:  2013-01-27       Impact factor: 49.962

4.  Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in beta-cells.

Authors:  C Chen; H Hosokawa; L M Bumbalo; J L Leahy
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 5.  New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36.

Authors:  Joep F F Brinkmann; Nada A Abumrad; Azeddine Ibrahimi; Ger J van der Vusse; Jan F C Glatz
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

6.  Genetic analysis of the cardiac methylome at single nucleotide resolution in a model of human cardiovascular disease.

Authors:  Michelle D Johnson; Michael Mueller; Martyna Adamowicz-Brice; Melissa J Collins; Pascal Gellert; Klio Maratou; Prashant K Srivastava; Maxime Rotival; Shahena Butt; Laurence Game; Santosh S Atanur; Nicholas Silver; Penny J Norsworthy; Sarah R Langley; Enrico Petretto; Michal Pravenec; Timothy J Aitman
Journal:  PLoS Genet       Date:  2014-12-04       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.